Lower Risk of Death and Kidney Failure Associated with Higher Target (vs. Below-Target) Doses of RAS Inhibitors in Octogenarians with HFrEF

By sjmartinez • November 18, 2024

Sin MK, Allman RM, Faselis C, Aronow WS, Brown CJ, Lam PH, Wu WC, Zeng-Treitler Q, Patel SS, Raman VK, Zhang S, Sheriff HM, Morgan CJ, Heidenreich PA, Fonarow GC, Ahmed A. Lower Risk of Death and Kidney Failure Associated with Higher Target (vs. Below-Target) Doses of RAS Inhibitors in Octogenarians with HFrEF. Am J Med. 2024 Nov 12:S0002-9343(24)00710-1. doi: 10.1016/j.amjmed.2024.10.019. Epub ahead of print. PMID: 39551174.

Tags: Cardiology/Epi, death, HFrEF, kidney failure, octogenarians, Publications, RAS Inhibitors, target dose

Discrepancy between reference phenotypic and genotypic detection of cphA metallo-β-lactamase in Aeromonas spp

von Bredow B, Trejo M, Ward KW, Trieu KP, Santellan CA, Garner OB, Yang S, Chandrasekaran S. Discrepancy between reference phenotypic and genotypic detection of cphA metallo-β-lactamase[...]

Plaque, P-Values, and Presentation Bias: Four Limitations of the EKSTROM Trial

Budoff MJ, Verghese D, Kinninger A, Lakshmanan S. Plaque, P-Values, and Presentation Bias: Four Limitations of the EKSTROM Trial. Eur Heart J Cardiovasc Imaging. 2026[...]

Timeliness of Transthyretin Cardiac Amyloidosis Diagnosis in the Medicare Population

Spencer-Bonilla G, Fan J, Cheng P, Din N, Rodriguez F, Davies M, Papas MA, Huang J, Venditto J, Witteles RM, Heidenreich P, Alexander K, Sandhu[...]